Paul A. Barsanti

1.2k total citations
19 papers, 785 citations indexed

About

Paul A. Barsanti is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Paul A. Barsanti has authored 19 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Paul A. Barsanti's work include DNA Repair Mechanisms (5 papers), Synthetic Organic Chemistry Methods (4 papers) and Cancer therapeutics and mechanisms (4 papers). Paul A. Barsanti is often cited by papers focused on DNA Repair Mechanisms (5 papers), Synthetic Organic Chemistry Methods (4 papers) and Cancer therapeutics and mechanisms (4 papers). Paul A. Barsanti collaborates with scholars based in United States, United Kingdom and Libya. Paul A. Barsanti's co-authors include Scott E. Denmark, Ken‐Tsung Wong, Robert A. Stavenger, Alan Armstrong, Lyn H. Jones, Dirksen E. Bussiere, Tyler W. Wilson, Zhi‐Jie Ni, Gregory L. Beutner and Weibo Wang and has published in prestigious journals such as Nature Communications, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Paul A. Barsanti

19 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul A. Barsanti United States 13 441 440 156 85 62 19 785
Kevin Blades United Kingdom 17 555 1.3× 576 1.3× 217 1.4× 46 0.5× 39 0.6× 28 1.0k
Bodo Scheiper Germany 12 609 1.4× 242 0.6× 88 0.6× 100 1.2× 62 1.0× 13 863
Robert D. Hubbard United States 16 653 1.5× 308 0.7× 130 0.8× 38 0.4× 67 1.1× 24 900
James J. Kowalczyk United States 9 326 0.7× 330 0.8× 188 1.2× 91 1.1× 27 0.4× 10 669
Paul A. Renhowe United States 18 617 1.4× 412 0.9× 83 0.5× 37 0.4× 56 0.9× 26 891
Thomas J. Beauchamp United States 11 507 1.1× 172 0.4× 153 1.0× 59 0.7× 76 1.2× 16 678
Michaël Prakesch Canada 15 324 0.7× 287 0.7× 64 0.4× 56 0.7× 48 0.8× 25 609
Tsunehiko Soga Japan 16 420 1.0× 307 0.7× 207 1.3× 73 0.9× 46 0.7× 36 711
Anne Mengel Germany 12 623 1.4× 414 0.9× 88 0.6× 92 1.1× 58 0.9× 18 967
Tucker R. Huffman United States 8 308 0.7× 334 0.8× 87 0.6× 51 0.6× 46 0.7× 9 628

Countries citing papers authored by Paul A. Barsanti

Since Specialization
Citations

This map shows the geographic impact of Paul A. Barsanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Barsanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Barsanti more than expected).

Fields of papers citing papers by Paul A. Barsanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Barsanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Barsanti. The network helps show where Paul A. Barsanti may publish in the future.

Co-authorship network of co-authors of Paul A. Barsanti

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Barsanti. A scholar is included among the top collaborators of Paul A. Barsanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Barsanti. Paul A. Barsanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lim, Pei Xin, Amber C. Donahue, Vidhya Nagarajan, et al.. (2025). Abstract 2899: PARG inhibition provokes a DNA damage-dependent innate immune reaction that enhances ICI-driven anti-tumor immunity. Cancer Research. 85(8_Supplement_1). 2899–2899. 1 indexed citations
2.
Muñoz, Diana M., Myra E. Conway, Arjun A. Rao, et al.. (2024). 349 (PB337): IDE161, a potential first-in-class clinical candidate PARG inhibitor, selectively targets solid tumors with replication stress and DNA repair vulnerabilities. European Journal of Cancer. 211. 114862–114862. 1 indexed citations
3.
Taygerly, Joshua P., Kathleen Boyle, Stephen E. Basham, et al.. (2019). Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nature Communications. 10(1). 1402–1402. 147 indexed citations
4.
Lu, Yipin, Mark Knapp, Kenneth Crawford, et al.. (2017). Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors. Journal of Molecular Biology. 429(11). 1684–1704. 28 indexed citations
5.
Menezes, Daniel L., Yan Tang, Jiajia Feng, et al.. (2014). A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function. Molecular Cancer Research. 13(1). 120–129. 78 indexed citations
6.
Barsanti, Paul A., Robert J. Aversa, Yue Pan, et al.. (2014). Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Medicinal Chemistry Letters. 6(1). 37–41. 30 indexed citations
7.
Barsanti, Paul A., Weibo Wang, Zhi‐Jie Ni, et al.. (2009). The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5. Bioorganic & Medicinal Chemistry Letters. 20(1). 157–160. 93 indexed citations
8.
Denmark, Scott E., Paul A. Barsanti, Gregory L. Beutner, & Tyler W. Wilson. (2007). Enantioselective Ring Opening of Epoxides with Silicon Tetrachloride in the Presence of a Chiral Lewis Base: Mechanism Studies. Advanced Synthesis & Catalysis. 349(4-5). 567–582. 55 indexed citations
9.
Denmark, Scott E., Paul A. Barsanti, Gregory L. Beutner, & Tyler W. Wilson. (2007). Enantioselective Lewis Acid-Lewis Base Ring Opening of Epoxides. Synfacts. 2007(6). 614–614. 3 indexed citations
10.
Ni, Zhi‐Jie, Paul A. Barsanti, Daniel J. Poon, et al.. (2006). 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3121–3124. 58 indexed citations
11.
Armstrong, Alan, et al.. (2003). Synthesis of the C1-side chain of zaragozic acid D and progress towards a total synthesis. Tetrahedron. 59(3). 367–375. 12 indexed citations
12.
Armstrong, Alan, et al.. (2000). Total Synthesis of (+)-Zaragozic Acid C. The Journal of Organic Chemistry. 65(21). 7020–7032. 42 indexed citations
13.
Denmark, Scott E., Paul A. Barsanti, Ken‐Tsung Wong, & Robert A. Stavenger. (1998). Enantioselective Ring Opening of Epoxides with Silicon Tetrachloride in the Presence of a Chiral Lewis Base. The Journal of Organic Chemistry. 63(8). 2428–2429. 140 indexed citations
14.
Armstrong, Alan, Lyn H. Jones, & Paul A. Barsanti. (1998). Total synthesis of (+)-zaragozic acid C. Tetrahedron Letters. 39(20). 3337–3340. 38 indexed citations
15.
Denmark, Scott E., Robert A. Stavenger, Stephen B. D. Winter, Ken‐Tsung Wong, & Paul A. Barsanti. (1998). Preparation of Chlorosilyl Enolates. The Journal of Organic Chemistry. 63(25). 9517–9523. 21 indexed citations
16.
Armstrong, Alan, Paul A. Barsanti, Paul A. Clarke, & Anthony Wood. (1996). Ketone-directed peracid epoxidation of cyclic alkenes. Journal of the Chemical Society Perkin Transactions 1. 1373–1373. 5 indexed citations
17.
Armstrong, Alan & Paul A. Barsanti. (1995). Synthesis of the Bicyclic Core of the Zaragozic Acids (Squalestatins). Synlett. 1995(9). 903–906. 14 indexed citations
18.
Armstrong, Alan, Paul A. Barsanti, Paul A. Clarke, & Anthony Wood. (1994). Ketone-directed peracid epoxidation. Tetrahedron Letters. 35(33). 6155–6158. 10 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin Blades Breakdown of academic impact, for papers by Bodo Scheiper Breakdown of academic impact, for papers by Robert D. Hubbard Breakdown of academic impact, for papers by James J. Kowalczyk Breakdown of academic impact, for papers by Paul A. Renhowe Breakdown of academic impact, for papers by Thomas J. Beauchamp Breakdown of academic impact, for papers by Michaël Prakesch Breakdown of academic impact, for papers by Tsunehiko Soga Breakdown of academic impact, for papers by Anne Mengel Breakdown of academic impact, for papers by Tucker R. Huffman
Rankless by CCL
2026